Publications by authors named "David Connor"

Claim this Profile
D
Do in-scanner tasks outperform rest for predicting autistic traits using functional connectivity data?
Corey Horien, Francesca Mandino, Abigail S Greene, Xilin Shen, Kelly Powell, David O' Connor

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spaghetti with meatballs or noodles: Microscopic structure of sclerosant-induced thrombus, sclerocoagulum and superficial venous thrombosis.
Osvaldo Cooley Andrade, David Ewan Connor, Elton Chee, John W Weisel, Kurosh Parsi

Phlebology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atraumatic grade five renal injury.
Phaedra Rampersad, Silas Webb, David Connor

BMJ Case Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic evidence for microsampling to support therapeutic drug monitoring: A systematic review.
Jane E Carland, David Connor, Mitchell Starr, Danijela Kocic, Tracey-Lea Laba

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiology or histopathology: the misdiagnosis of benign and malignant tumors as vascular anomalies.
Manisha Siriwardene, Nikita Naidu, Sewon Kim, Christopher Rogan, Karen Cheung, David E Connor

Int Angiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regarding: Endovenous treatment for varicose veins of the lower limbs: Comparative histological evaluation of different techniques.
Manisha Siriwardene, David E Connor, Kurosh Parsi

Phlebology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.
Joseph Gracé, David Connor, Kurosh Parsi

Phlebology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants.
Kurosh Parsi, Marianne De Maeseneer, Andre M van Rij, Christopher Rogan, Wendy Bonython, David E Connor

Phlebology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher soluble thrombomodulin and angiogenic markers in continuous flow left ventricular assist device-supported patients associated with arteriovenous malformation and nonsurgical bleeding.
Kavitha Muthiah, Louise L Dunn, Hunter Eckford, David Connor, Desiree Robson

JHLT Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of post-thrombotic syndrome: International union of phlebology (UIP) survey of medical specialists.
Nuo Xu, Manisha Siriwardene, Nikita Naidu, David E Connor, Alun H Davies

Phlebology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.
Kurosh Parsi, Joseph Grace, David Connor

Phlebology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sclerotherapy: Indications and safety volumes.
Matthew Tan, Hernan Bauza Moreno, Beate Bechter-Hugl, Sergio Gianesini, David Connor

Phlebology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
8
899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.
Kurosh Parsi, Lois Zhang, Mark S Whiteley, Selene Vuong, Mina Kang, David E Connor

Phlebology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.
Joseph Gracé, David Connor, Lourens Bester, Christopher Rogan, Kurosh Parsi

Phlebology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders.
Lois Zhang, Kate Ng, James P Pham, Samuel Thoo, Anes Yang, David Connor

Phlebology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023.
Mandy Wong, Kurosh Parsi, Kenneth Myers, Marianne De Maeseneer, Joseph Caprini, David E Connor

Phlebology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume.
David Connor, David Rabbolini, Marie-Christine Morel-Kopp, Kate Fixter, Dea Donikian

Platelets· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia.
Hannah Hsu, Melissa V Chan, Paul C Armstrong, Marilena Crescente, Dea Donikian, David Connor

Pathology· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies.
Mina Kang, Anes Yang, Patricia Hannaford, David Connor, Kurosh Parsi

Phlebology· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms.
Mina Kang, Anes Yang, Patricia Hannaford, David Connor, Kurosh Parsi

Phlebology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.
Kurosh Parsi, Burcu Kim, Alicia A O'Connor, Pooja Kadam, David Connor

Phlebology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes.
Mina Kang, David E Connor, Kurosh Parsi

Phlebology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
Christine S M Lee, Hai Po Helena Liang, David E Connor, Agnibesh Dey, Ibrahim Tohidi-Esfahani

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin-induced takotsubo cardiomyopathy.
Wiktoria Julia Kotts, David T Gamble, Dana K Dawson, David Connor

BMJ Case Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology.
Andrew L Frelinger, José Rivera, David E Connor, Kathleen Freson, Andreas Greinacher

J Thromb Haemost· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis